Tamoxifen: new membrane-mediated mechanisms of action and therapeutic advances

This publication has 35 references indexed in Scilit:

• Tamoxifen and related compounds decrease membrane fluidity in liposomes
  FEBS Letters, 1993
• N‐Acetylcysteine inhibits apoptosis and decreases viral particles in HIV‐chronically infected U937 cells
  FEBS Letters, 1993
• Vitamin D is a membrane antioxidant Ability to inhibit iron‐dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action
  FEBS Letters, 1993
• Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma
  Digestive Diseases and Sciences, 1992
• Droloxifene, a new anti-oestrogen in postmenopausal advanced breast cancer: Preliminary results of a double-blind dose-finding phase II trial
  European Journal Of Cancer, 1992
• The antioxidant action of ketoconazole and related azoles: Comparison with tamoxifen and cholesterol
  Chemico-Biological Interactions, 1991
• Growth inhibition and the regulation of cyclic AMP by the triphenylethylene anti‐estrogen tamoxifen in the quail oviduct
  Biology of the Cell, 1991
• Mechanism of inhibition of lipid peroxidation by tamoxifen and 4‐hydroxytamoxifen introduced into liposomes
  FEBS Letters, 1990
• Book ReviewAmbulatory Pediatric Care
  New England Journal of Medicine, 1989
• Lipid peroxidation and fluidity of plasma membranes from rat liver and Morris hepatoma 3924A
  FEBS Letters, 1984